A Phase I trial of PLZ4-coated paclitaxel-loaded micelles in patients with refractory non–muscle-invasive bladder cancer
Open Access
- 1 June 2026
- journal article
- method
- Published by Taylor & Francis in Nanomedicine
- Vol. 21 (12) , 1707-1712
Abstract
1. 1.1. Non-muscle-invasive bladder cancer (NMIBC) is the most common stage of bladder cancer, accounting for roughly 75% of patients with bladder cancer and can recur despite treatment with transu...Keywords
Funding Information
- Comprehensive Cancer Center, University of California, Davis
- National Cancer Institute (P30CA093373)
- U.S. Department of Veterans Affairs (I01CX002247)
This publication has 15 references indexed in Scilit:
- TAR-200 for Bacillus Calmette-Guérin–Unresponsive High-Risk Non–Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 StudyJournal of Clinical Oncology, 2025
- Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trialThe Lancet Oncology, 2024
- IL-15 Superagonist NAI in BCG-Unresponsive Non–Muscle-Invasive Bladder CancerNEJM Evidence, 2023
- Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trialThe Lancet Oncology, 2020
- Bladder CancerJAMA, 2020
- Long-term Survival Outcomes With Intravesical Nanoparticle Albumin-bound Paclitaxel for Recurrent Non–muscle-invasive Bladder Cancer After Previous Bacillus Calmette-Guérin TherapyUrology, 2017
- Blood–Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma TherapyACS Nano, 2016
- Clinical model of lifetime cost of treating bladder cancer and associated complicationsUrology, 2006
- Taxol: A Novel Investigational Antimicrotubule AgentJNCI: Journal of the National Cancer Institute, 1990
- Long-Term Results and Complications of Intracavitary Bacillus Calmette-Guerin Therapy for Bladder CancerJournal of Urology, 1984